Ablation with Low-Dose(1.1GBq) and High-Dose(3.7GBq) Radioiodine in Postoperative Low and Intermediate Risk Differentiated Thyroid Cancer

被引：0
|
作者：
Qu, Yuan [1 ]
Huang, Rui [1 ]
Li, Lin [1 ]
机构：
[1] West China Hosp, Chengdu, Sichuan, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1775
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Ablation with Low-Dose versus High-Dose Radioiodine in differentiated Thyroid Cancer
    Elrasad, S. A. A.
    Elhoseini, M. A.
    Abdelmeguid, R.
    Elrefaei, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S540 - S540
  • [2] Clinical outcomes of low-dose and high-dose postoperative radioiodine therapy in patients with intermediate-risk differentiated thyroid cancer
    Jeong, Ju Hye
    Kong, Eun Jung
    Jeong, Shin Young
    Lee, Sang-Woo
    Cho, Ihn Ho
    Chun, Kyung Ah
    Lee, Jaetae
    Ahn, Byeong-Cheol
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (03) : 228 - 233
  • [3] Development of a predictive nomogram for intermediate-risk differentiated thyroid cancer patients after fixed 3.7GBq (100mCi) radioiodine remnant ablation
    Lu, Lu
    Li, Qiang
    Ge, Zhao
    Lu, Yanqi
    Lin, Chunhao
    Lv, Jinfu
    Huang, Jinquan
    Mu, Xingyu
    Fu, Wei
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [4] Randomised comparison of 1.1 GBq and 3.7 GBq radioiodine to ablate the thyroid in the treatment of low-risk thyroid cancer: a 13-year follow-up
    Ahtiainen, Veera
    Vaalavirta, Leila
    Tenhunen, Mikko
    Joensuu, Heikki
    Maenpaa, Hanna
    ACTA ONCOLOGICA, 2020, 59 (09) : 1064 - 1071
  • [5] Low-Dose Radioiodine Ablation in Patients with Low-Risk Differentiated Thyroid Cancer
    Jimenez Londono, German A.
    Garcia Vicente, Ana Maria
    Sastre Marcos, Julia
    Pena Pardo, Francisco Jose
    Amo-Salas, Mariano
    Moreno Caballero, Manuel
    Talavera Rubio, Maria Prado
    Gonzalez Garcia, Beatriz
    Disotuar Ruiz, Niletys Dafne
    Soriano Castrejon, Angel Maria
    EUROPEAN THYROID JOURNAL, 2018, 7 (04) : 218 - 224
  • [6] Long-term recurrence of thyroid cancer after thyroid remnant ablation with 1.1 and 3.7 GBq radioiodine
    Rosario, Pedro W. S.
    Purisch, Saulo
    Vasconcelos, Flavio P. J.
    Padrao, Eduardo L.
    Rezende, Leonardo L.
    Barroso, Alvaro L.
    NUCLEAR MEDICINE COMMUNICATIONS, 2007, 28 (06) : 507 - 508
  • [7] LOW-DOSE AND HIGH-DOSE RADIOIODINE IN THYROID CANCER - REPLY
    MCCOWEN, KD
    AMERICAN JOURNAL OF MEDICINE, 1977, 63 (01): : 167 - 168
  • [8] Low dose radioactive iodine ablation therapy (1.11 GBq) for differentiated thyroid cancer in western Turkey
    Erkek, B. Karasah
    Gumusgoz, H. Sariyildiz
    Oral, A.
    Yazici, B.
    Akgun, A.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2024, 43 (06):
  • [9] Success rate of thyroid remnant ablation with a fixed activity of 2 GBq radioiodine in low and high risk patients with differentiated thyroid cancer
    Dunkelmann, S.
    Pawelzig, A.
    Knieling, A.
    Schwarzenboeck, S.
    Schuemichen, C.
    Krause, B. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S348 - S348
  • [10] Clinical outcome of postoperative radioiodine therapy with high dose and low dose in intermediate risk differentiated thyroid cancer patients
    Jeong, J.
    Kong, E.
    Jeong, S.
    Lee, S.
    Lee, J.
    Chun, K.
    Ahn, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S161 - S161
12345